Cosmos Health signs five-year Greece deal for diabetes drug DIABIT-IS X

Libytec Pharmaceutical will distribute and promote the sitagliptin medicine, which Cosmos Health says should support revenue and cash-flow visibility and widen access through Greece’s public insurance system.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.